NCT02226068View on ClinicalTrials.gov

Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

January 31, 2004

Conditions
Atopic Dermatitis
Interventions
DRUG

Cyclosporine A (CsA)

3 mg/kg/day for 4 month

OTHER

Extracorporeal photopheresis (ECP)

Administered two consecutive days twice a month for 4 month

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT02226068 - Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter